by EmpathiCSubstanceS | Jul 13, 2020 | MDMA Sassafras Molly, PTSD
Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the results of an interim analysis of the data from the first of its two Phase 3 clinical trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). This...
by EmpathiCSubstanceS | Jun 12, 2020 | PTSD
A new study published in the journal Psychopharmacology is presenting a comprehensive look at the long-term efficacy of MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorder (PTSD). The study finds not only do the substantial beneficial...
by EmpathiCSubstanceS | Apr 8, 2020 | MDMA Sassafras Molly, PTSD
[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Bipolar Disorder, Depression, PTSD
Many use kratom to quit opioids; others just want to get high. There’s a push to regulate the plant-derived drug—but experts disagree on its safety. By her mid-20s, Faith Day was out of jail but homeless. She was also addicted to a substance now too legally...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, PTSD
One of the more compelling areas of research currently being investigated in the world of psychedelic science is psilocybin-assisted psychotherapy to improve emotional well-being in patients with life-threatening cancer. A new study is offering the first long-term...
by EmpathiCSubstanceS | Feb 8, 2020 | Cancer, Pain, PTSD
A team of researchers from King’s College London has, for the first time, imaged the brains of patients with psychosis under the influence of cannabidiol (CBD). The study demonstrates the anti-psychotic potential of CBD, suggesting large clinical trials are necessary....
